Sang Hee Park - Related publications

Stony Brook University, Stony Brook, NY, United States 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2019 Ding Y, Ding K, Yu K, Zou D, Yang H, He X, Mo W, Yu X, Ding X. Prognosis and endocrine therapy selection for patients with low hormone receptor-positive breast cancer following neoadjuvant chemotherapy: A retrospective study of 570 patients in China. Oncology Letters. 18: 6690-6696. PMID 31807179 DOI: 10.3892/ol.2019.11033   
2019 Zodinpuii D, Pautu JL, Zothankima B, Pachuau L, Kumar NS. Clinical features and first degree relative breast cancer, their correlation with histological tumor grade: a 5-year retrospective case study of breast cancer in Mizoram, India. Environmental Science and Pollution Research International. PMID 31768959 DOI: 10.1007/s11356-019-06944-8   
2019 Koenig JL, Kozak MM, Sabolch A, Horst K, Tsai J, Wapnir IL, Pollom E. Use of Preoperative Radiation Therapy in Early-stage and Locally Advanced Breast Cancer. Cureus. 11: e5748. PMID 31723509 DOI: 10.7759/cureus.5748   
2019 Koenig JL, Kozak MM, Sabolch A, Horst K, Tsai J, Wapnir IL, Pollom E. Use of Preoperative Radiation Therapy in Early-stage and Locally Advanced Breast Cancer. Cureus. 11: e5748. PMID 31723509 DOI: 10.7759/cureus.5748   
2019 Feng C, Yu D, Qian J. Long-Term Results and Predictors of Survival After Conservative Breast Surgery for Breast Cancer During Pregnancy. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 25: 8587-8594. PMID 31725704 DOI: 10.12659/MSM.917288   
2019 Zhang Y, Li Z, Chen M, Chen H, Zhong Q, Liang L, Li B. Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction. Dna and Cell Biology. PMID 31647329 DOI: 10.1089/dna.2019.5059   
2019 Li NN, Bai CM, Zhao L, Ge YP. [Gut Microbiome Differences between Gastrointestinal Cancer Patients and Healthy People]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae. 41: 636-645. PMID 31699194 DOI: 10.3881/j.issn.1000-503X.11372   
2019 Lambertini M, Poggio F, Bruzzone M, Conte B, Bighin C, de Azambuja E, Giuliano M, De Laurentiis M, Cognetti F, Fabi A, Bisagni G, Durando A, Turletti A, Urracci Y, Garrone O, ... , et al. Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: exploratory analysis of the GIM2 trial. International Journal of Cancer. PMID 31724170 DOI: 10.1002/ijc.32789   
2019 Matsuda A, Inoue K, Momiyama M, Kobayashi K, Kubota K, Ohkubo T, Fischer MJ, Kroep JR, Ramai SSRS, Kaptein AA, Yamaoka K. Validity and Reliability of the Japanese Version of the 10-Item Perceived Efficacy in Patient-Physician Interactions (PEPPI-10) Scale in Breast Cancer Outpatients. The Tohoku Journal of Experimental Medicine. 249: 121-126. PMID 31656242 DOI: 10.1620/tjem.249.121   
2019 Huang YH, Lee MS, Lou YS, Lai HC, Yu JC, Lu CH, Wong CS, Wu ZF. Propofol-based total intravenous anesthesia did not improve survival compared to desflurane anesthesia in breast cancer surgery. Plos One. 14: e0224728. PMID 31697743 DOI: 10.1371/journal.pone.0224728   
2019 Gardner AB, Charo LM, Mann AK, Kapp DS, Eskander RN, Chan JK. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes. Clinical & Experimental Metastasis. PMID 31758289 DOI: 10.1007/s10585-019-10007-0   
2019 Takanashi T, Hikino H, Makino Y, Murata Y. Durable clinical benefit of letrozole in leptomeningeal metastasis of breast cancer. International Cancer Conference Journal. 8: 146-148. PMID 31559112 DOI: 10.1007/s13691-019-00372-8   
2019 Li X, Dai D, Chen B, He S, Zhang J, Wen C, Wang B. Prognostic Values Of Preoperative Serum CEA And CA125 Levels And Nomograms For Young Breast Cancer Patients. Oncotargets and Therapy. 12: 8789-8800. PMID 31695434 DOI: 10.2147/OTT.S221335   
2019 Ross MS, Chandler CK, Matsuo K, Vargo JA, Elishaev E, Siripong N, Berger JL, Kelley JL, Taylor SE. Cancer antigen 125 is associated with disease status in uterine carcinosarcoma. Rare Tumors. 11: 2036361319884159. PMID 31741727 DOI: 10.1177/2036361319884159   
2019 Zhang G, Chi N, Lu Q, Zhu D, Zhuang Y. LncRNA PTCSC3 Is a Biomarker for the Treatment and Prognosis of Gastric Cancer. Cancer Biotherapy & Radiopharmaceuticals. PMID 31702383 DOI: 10.1089/cbr.2019.2991   
2019 Li Y, Jiao Y, Luo Z, Li Y, Liu Y. High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancer. Medicine. 98: e17703. PMID 31689799 DOI: 10.1097/MD.0000000000017703   
2019 Naoi Y, Saito Y, Kishi K, Shimoda M, Kagara N, Miyake T, Tanei T, Shimazu K, Kim SJ, Noguchi S. Development of recurrence risk score using 95‑gene classifier and its application to formalin‑fixed paraffin‑embedded tissues in ER‑positive, HER2‑negative and node‑negative breast cancer. Oncology Reports. PMID 31638234 DOI: 10.3892/or.2019.7358   
2019 Peng Y, Chen R, Qu F, Ye Y, Fu Y, Tang Z, Wang Y, Zong B, Yu H, Luo F, Liu S. Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients. Cancer Biology & Therapy. 1-8. PMID 31684807 DOI: 10.1080/15384047.2019.1680057   
2019 Papadakos KS, Darlix A, Jacot W, Blom AM. High Levels of Cartilage Oligomeric Matrix Protein in the Serum of Breast Cancer Patients Can Serve as an Independent Prognostic Marker. Frontiers in Oncology. 9: 1141. PMID 31737569 DOI: 10.3389/fonc.2019.01141   
2019 Wang R, Zhu Y, Liu X, Liao X, He J, Niu L. The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer. Bmc Cancer. 19: 1091. PMID 31718602 DOI: 10.1186/s12885-019-6311-z   
2019 Zati Zehni A, Jacob SN, Mumm JN, Heidegger HH, Ditsch N, Mahner S, Jeschke U, Vilsmaier T. Hormone Receptor Expression in Multicentric/Multifocal versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality. International Journal of Molecular Sciences. 20. PMID 31731733 DOI: 10.3390/ijms20225740   
2019 Taubenhansl C, Ortmann O, Gerken M, Inwald EC, Klinkhammer-Schalke M. Guideline-concordant chemotherapy in patients with hormone receptor-positive and node-positive, early breast cancer leads to better overall and metastases-free survival with limited benefit in elderly patients. Archives of Gynecology and Obstetrics. PMID 31749031 DOI: 10.1007/s00404-019-05387-3   
2019 Grassmann F, He W, Eriksson M, Gabrielson M, Hall P, Czene K. Interval breast cancer is associated with other types of tumors. Nature Communications. 10: 4648. PMID 31641120 DOI: 10.1038/s41467-019-12652-1   
2019 Park J, Shin Y, Kim TH, Kim DH, Lee A. Plasma metabolites as possible biomarkers for diagnosis of breast cancer. Plos One. 14: e0225129. PMID 31794572 DOI: 10.1371/journal.pone.0225129   
2019 Larsson JK, Dabos KJ, Höglund P, Bohr J, Münch A, Giannakou A, Nemeth A, Wurm-Johansson G, Toth E, Plevris JN, Fineron P, Koulaouzidis A, Sjöberg K. Cancer Risk in Collagenous Colitis. Journal of Clinical Medicine. 8. PMID 31718057 DOI: 10.3390/jcm8111942   
2019 Tang J, Cui Q, Zhang D, Kong D, Liao X, Ren J, Gong Y, Wu G. A prognostic eight-lncRNA expression signature in predicting recurrence of ER-positive breast cancer receiving endocrine therapy. Journal of Cellular Physiology. PMID 31663114 DOI: 10.1002/jcp.29352   
2019 Jiao Y, Li Y, Fu Z, Hou L, Chen Q, Cai Y, Jiang P, He M, Yang Z. Expression as a Prognostic Biomarker for Liver Cancer Patients. Disease Markers. 2019: 9037131. PMID 31781311 DOI: 10.1155/2019/9037131   
2019 Woo S, Han S, Kim TH, Suh CH, Westphalen AC, Hricak H, Zelefsky MJ, Vargas HA. Prognostic Value of Pretreatment MRI in Patients With Prostate Cancer Treated With Radiation Therapy: A Systematic Review and Meta-Analysis. Ajr. American Journal of Roentgenology. 1-8. PMID 31799874 DOI: 10.2214/AJR.19.21836   
2019 Jung GH, Kim JH, Chung MS. Changes in weight, body composition, and physical activity among patients with breast cancer under adjuvant chemotherapy. European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society. 44: 101680. PMID 31756674 DOI: 10.1016/j.ejon.2019.101680   
2019 Matsui A, Murata Y, Masuda N, Mori K, Takahashi M, Yamashiro K, Aogi K, Maeda S, Itou M, Ozaki S, Kuraoka K, Satou Y, Ichihara S, Tokunaga E, Taguchi K, et al. Clinical significance of evaluating hormone receptor and HER2 protein using cell block against metastatic breast cancer: a multi-institutional study. Oncotarget. 10: 5680-5689. PMID 31620243 DOI: 10.18632/oncotarget.27163   
2019 Chen J, Easwaralingam N, Warrier S, Ong A, Carson EK, Mak C, Snook K, Middleton K, Parker A, Palmieri C, Spillane A, Mann GB, Lim E, Segara D. Window of opportunity treatment in breast cancer. Anz Journal of Surgery. PMID 31770829 DOI: 10.1111/ans.15487   
2019 Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. Challenges in liver cancer and possible treatment approaches. Biochimica Et Biophysica Acta. Reviews On Cancer. 188314. PMID 31682895 DOI: 10.1016/j.bbcan.2019.188314   
2019 Kwon MJ. Emerging immune gene signatures as prognostic or predictive biomarkers in breast cancer. Archives of Pharmacal Research. PMID 31707598 DOI: 10.1007/s12272-019-01189-y   
2019 Shiraishi T, Kano M, Sakata H, Murakami K, Toyozumi T, Sekino N, Okada K, Kamata T, Ryuzaki T, Matsubara H. [Successful Treatment of Gastric Cancer with Conversion Surgery after Nivolumab Treatment-A Case Report]. Gan to Kagaku Ryoho. Cancer & Chemotherapy. 46: 1614-1616. PMID 31631152   
2019 Bulut N, Ulas A, Altundag K. Favorable results of patients with pT1a, b, c, lymph node-negative early breast cancer in the long interval. Journal of Cancer Research and Therapeutics. 15: 1051-1056. PMID 31603109 DOI: 10.4103/jcrt.JCRT_1275_16   
2019 Azad TD, Chaudhuri AA, Fang P, Qiao Y, Esfahani MS, Chabon JJ, Hamilton EG, Yang YD, Lovejoy A, Newman AM, Kurtz DM, Jin M, Schroers-Martin J, Stehr H, Liu CL, et al. Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer. Gastroenterology. PMID 31711920 DOI: 10.1053/j.gastro.2019.10.039   
2019 Bayati M, Molavynejad S, Taheri N, Cheraghian B. Investigating the effect of Integrated Educational Program on the Quality of Life among Cancer Patients: A Clinical Trial Study. Asian Pacific Journal of Cancer Prevention : Apjcp. 20: 3457-3463. PMID 31759372 DOI: 10.31557/APJCP.2019.20.11.3457   
2019 Lipps DB, Leonardis JM, Dess RT, McGinnis GJ, Marsh RB, Strauss JB, Hayman JA, Pierce LJ, Jagsi R. Mechanical properties of the shoulder and pectoralis major in breast cancer patients undergoing breast-conserving surgery with axillary surgery and radiotherapy. Scientific Reports. 9: 17737. PMID 31780712 DOI: 10.1038/s41598-019-54100-6   
2019 Guccione L, Gough K, Drosdowsky A, Fisher K, Price T, Pavlakis N, Khasraw M, Wyld D, Ransom D, Kong G, Rogers M, Leyden S, Leyden J, Michael M, Schofield P. Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention. Jmir Research Protocols. 8: e14361. PMID 31793892 DOI: 10.2196/14361   
2019 Feng J, Hu J, Xia Y. Identification of RAD54 homolog B as a promising therapeutic target for breast cancer. Oncology Letters. 18: 5350-5362. PMID 31612045 DOI: 10.3892/ol.2019.10854   
2019 Shen N, Wang T, Li D, Zhu Y, Xie H, Lu Y. Hypermethylation of the SEPT9 Gene Suggests Significantly Poor Prognosis in Cancer Patients: A Systematic Review and Meta-Analysis. Frontiers in Genetics. 10: 887. PMID 31608117 DOI: 10.3389/fgene.2019.00887   
2019 Milanese JS, Tibiche C, Zou J, Meng Z, Nantel A, Drouin S, Marcotte R, Wang E. Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients. Npj Precision Oncology. 3: 28. PMID 31701019 DOI: 10.1038/s41698-019-0100-7   
2019 Cui Q, Tang J, Zhang D, Kong D, Liao X, Ren J, Gong Y, Xie C, Wu G. A prognostic eight-gene expression signature for patients with breast cancer receiving adjuvant chemotherapy. Journal of Cellular Biochemistry. PMID 31692061 DOI: 10.1002/jcb.29550   
2019 Xiang HY, Liu YH, Zhang H, Zhang S, Xin L, Xu L, Ye JM, Li T, Duan XN, Liu Q. Clinicopathologic analysis of 722 breast cancer patients who met the inclusion criteria of the TAILORx trial. Chinese Medical Journal. PMID 31809316 DOI: 10.1097/CM9.0000000000000548   
2019 Karaköse M, Çordan İ, Can M, Kocabaş M, Kulaksızoğlu M, Karakurt F. Incidence of second primary malignancies in patients with thyroid cancer in the Turkish population Turkish Journal of Medical Sciences. 49: 1529-1533. PMID 31651125 DOI: 10.3906/sag-1903-104   
2019 Bilen MA, Martini DJ, Liu Y, Shabto JM, Brown JT, Williams M, Khan AI, Speak A, Lewis C, Collins H, Kissick HT, Carthon BC, Akce M, Shaib WL, Alese OB, et al. Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy. The Oncologist. PMID 31806781 DOI: 10.1634/theoncologist.2019-0751   
2019 Sesti J, Sikora TJ, Turner DS, Turner AL, Langan RC, Nguyen AB, Paul S. Disparities in Follow-up After Low-Dose Lung Cancer Screening. Seminars in Thoracic and Cardiovascular Surgery. PMID 31626913 DOI: 10.1053/j.semtcvs.2019.10.006   
2019 Chen WX, Lou M, Cheng L, Qian Q, Xu LY, Sun L, Zhu YL, Dai H. Bioinformatics analysis of potential therapeutic targets among genes in breast cancer. Oncology Letters. 18: 6017-6025. PMID 31788076 DOI: 10.3892/ol.2019.10949   
2019 Walkiewicz K, Strzelczyk J, Waniczek D, Biernacki K, Muc-Wierzgoń M, Copija A, Nowakowska-Zajdel E. Adamalysines as Biomarkers and a Potential Target of Therapy in Colorectal Cancer Patients: Preliminary Results. Disease Markers. 2019: 5035234. PMID 31565100 DOI: 10.1155/2019/5035234   
2019 Liu Z, Chen S, Huang Y, Hu D, Wang M, Wei W, Zhang C, Zeng W, Guo L. Patients Aged ≥55 Years With Stage T1-2N1M1 Differentiated Thyroid Cancer Should Be Downstaged in the Eighth Edition AJCC/TNM Cancer Staging System. Frontiers in Oncology. 9: 1093. PMID 31681617 DOI: 10.3389/fonc.2019.01093